In the News
Aerium Therapeutics
Aerium Therapeutics Advances Next Generation Antibodies to Protect Immunocompromised Persons Against COVID-19
October 4, 2023
MedCity News
Startup Nuvig Therapeutics gets $47M to bring immune system back into balance
May 11, 2022
Bristol Myers Squibb
PR Newswire
Bridge Medicines Enters Exclusive License Agreement with The Rockefeller University for Novel Epigenetic Leukemia Program
March 16, 2020
Gilead
Gilead Sciences Licenses Portfolio of HIV Antibodies From The Rockefeller University
January 9, 2020